Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

Edelman KJ, He Q, Makinen JP, Haanpera MS, Tran Minh NN, Schuerman L, Wolter J, Mertsola JA.

Clin Infect Dis. 2004 Jul 15;39(2):179-85. Epub 2004 Jul 2.

PMID:
15307026
2.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
3.

Immunity to pertussis 5 years after booster immunization during adolescence.

Edelman K, He Q, Mäkinen J, Sahlberg A, Haanperä M, Schuerman L, Wolter J, Mertsola J.

Clin Infect Dis. 2007 May 15;44(10):1271-7. Epub 2007 Apr 2.

PMID:
17443462
4.

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, Riffelmann M, Wirsing von König CH, Liese J.

Vaccine. 2008 Dec 9;26(52):6929-35. doi: 10.1016/j.vaccine.2008.09.064. Epub 2008 Oct 11.

PMID:
18852002
5.

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.

Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.

Pediatrics. 2006 Apr;117(4):1084-93.

PMID:
16585302
6.

Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens.

Scheifele DW, Ochnio JJ, Halperin SA.

Pediatr Infect Dis J. 2009 Nov;28(11):985-9. doi: 10.1097/INF.0b013e3181a9cc2a.

PMID:
19755930
7.
8.

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.

Cassone A, Ausiello CM, Urbani F, Lande R, Giuliano M, La Sala A, Piscitelli A, Salmaso S.

Arch Pediatr Adolesc Med. 1997 Mar;151(3):283-9.

PMID:
9080938
9.

Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.

Meyer CU, Zepp F, Decker M, Lee M, Chang SJ, Ward J, Yoder S, Bogaert H, Edwards KM.

Clin Vaccine Immunol. 2007 Mar;14(3):288-92. Epub 2007 Jan 31.

10.

Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children.

Tran Minh NN, Edelman K, He Q, Viljanen MK, Arvilommi H, Mertsola J.

Vaccine. 1998 Oct;16(17):1604-10.

PMID:
9713935
11.

Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.

Tran Minh NN, He Q, Ramalho A, Kaufhold A, Viljanen MK, Arvilommi H, Mertsola J.

Pediatrics. 1999 Dec;104(6):e70.

PMID:
10586004
12.

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.

Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM.

Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052. Epub 2009 Sep 1.

PMID:
19729085
13.

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.

Huang LM, Lee CY, Lin TY, Chen JM, Lee PI, Hsu CY.

Vaccine. 1996 Jun;14(9):916-22.

PMID:
8843635
14.

Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.

Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM.

Vaccine. 2011 Aug 5;29(34):5725-30. doi: 10.1016/j.vaccine.2011.05.094. Epub 2011 Jun 12.

PMID:
21669247
15.

Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine.

Barreto L, Guasparini R, Meekison W, Noya F, Young L, Mills E.

Vaccine. 2007 Nov 23;25(48):8172-9. Epub 2007 Oct 2.

PMID:
17945400
16.

Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.

Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A.

J Infect Dis. 2000 Jun;181(6):1989-95. Epub 2000 Jun 5.

PMID:
10837180
17.
18.

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM.

Vaccine. 2004 Dec 2;23(3):380-5.

PMID:
15530684
19.

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Habermehl P, Knuf M, Mannhardt-Laakman W, Howe B, Friedland LR.

Vaccine. 2007 Jul 20;25(29):5248-52. Epub 2007 Jun 4.

PMID:
17583395
20.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526

Supplemental Content

Support Center